Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuke Okabayashi

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Nihon Jinzo Gakkai Shi|October 31, 2018
Glomerular lesions in various types of glomerulonephritisYusuke Okabayashi, Akira Shimizu
Seminars in Nephrology|October 30, 2021
The Renal Pathology of Obesity: Structure-Function CorrelationsNobuo Tsuboi, Yusuke Okabayashi
Kidney International Reports|March 18, 2021
Response to Obesity-Related Glomerulopathy: Hyperfiltration may Contribute to early ProteinuriaYusuke Okabayashi, Nobuo Tsuboi
The Lancet Regional Health. Europe|March 24, 2025
Nephrology referral for chronic kidney disease patientsYusuke Okabayashi, Takaya Sasaki, Nobuo Tsuboi
International Journal of Obesity (2005)|July 4, 2024
Podocyte injury in extreme obesityNobuo Tsuboi, Yusuke Okabayashi, Kotaro Haruhara
Kidney International Reports|November 17, 2017
The Renal Pathology of ObesityNobuo Tsuboi, Yusuke Okabayashi, Akira Shimizu, et al.
CEN Case Reports|June 22, 2026
Does pregnancy modify disease activity in C3 glomerulopathy?Yuya Yamaguchi, Yusuke Okabayashi, Masahiro Okabe, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|February 2, 2021
Assessment of nephron number and single-nephron glomerular filtration rate in a clinical settingNobuo Tsuboi, Takaya Sasaki, Yusuke Okabayashi, et al.
Kidney International|August 13, 2019
Group 1 innate lymphoid cells are involved in the progression of experimental anti-glomerular basement membrane glomerulonephritis and are regulated by peroxisome proliferator-activated receptor αYusuke Okabayashi, Shinya Nagasaka, Go Kanzaki, et al.
Clinical Kidney Journal|May 16, 2025
Age-related glomerular loss in patients with IgA nephropathyHirokazu Marumoto, Nobuo Tsuboi, Takaya Sasaki, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Nihon Jinzo Gakkai Shi|October 31, 2018
Glomerular lesions in various types of glomerulonephritisYusuke Okabayashi, Akira Shimizu
Seminars in Nephrology|October 30, 2021
The Renal Pathology of Obesity: Structure-Function CorrelationsNobuo Tsuboi, Yusuke Okabayashi
Kidney International Reports|March 18, 2021
Response to Obesity-Related Glomerulopathy: Hyperfiltration may Contribute to early ProteinuriaYusuke Okabayashi, Nobuo Tsuboi
The Lancet Regional Health. Europe|March 24, 2025
Nephrology referral for chronic kidney disease patientsYusuke Okabayashi, Takaya Sasaki, Nobuo Tsuboi
International Journal of Obesity (2005)|July 4, 2024
Podocyte injury in extreme obesityNobuo Tsuboi, Yusuke Okabayashi, Kotaro Haruhara
Kidney International Reports|November 17, 2017
The Renal Pathology of ObesityNobuo Tsuboi, Yusuke Okabayashi, Akira Shimizu, et al.
CEN Case Reports|June 22, 2026
Does pregnancy modify disease activity in C3 glomerulopathy?Yuya Yamaguchi, Yusuke Okabayashi, Masahiro Okabe, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|February 2, 2021
Assessment of nephron number and single-nephron glomerular filtration rate in a clinical settingNobuo Tsuboi, Takaya Sasaki, Yusuke Okabayashi, et al.
Kidney International|August 13, 2019
Group 1 innate lymphoid cells are involved in the progression of experimental anti-glomerular basement membrane glomerulonephritis and are regulated by peroxisome proliferator-activated receptor αYusuke Okabayashi, Shinya Nagasaka, Go Kanzaki, et al.
Clinical Kidney Journal|May 16, 2025
Age-related glomerular loss in patients with IgA nephropathyHirokazu Marumoto, Nobuo Tsuboi, Takaya Sasaki, et al.
Pageof 7